SpaceX Stock Is 169% Overvalued According to Experts. Here's Why.

SpaceX IPO was priced at $135/share, quickly running to ~$225, and still trades around ~$170 after a correction. Morningstar is “pumping the brakes,” valuing SpaceX at ~$63/share—about 63% below the current ~$170 level—arguing the valuation math depends on unrealized milestones like rapid reuse of Starship and commercialization of space data centers not expected until at least 2028. Even in Morningstar’s most optimistic moonshot case (about $154/share), the analysis suggests the stock is still priced above fair value.

Analysis

This is mostly a sentiment event, not a public-market earnings catalyst. The important read-through is to late-stage private tech: when a marquee name is challenged on valuation, secondary buyers usually become more selective across the whole growth complex, which can pressure marks before it ever shows up in operating results. That means the real spillover is to venture funds, crossover investors, and any listed proxy that trades on scarce-duration narratives, not to near-term cash-flow names.

The bearish case is strongest over 1-3 months if there is no fresh funding print or operating milestone to anchor the mark. If secondary liquidity dries up or discount-to-last-round widens, the downside is a tighter capital cycle for adjacent space/satellite suppliers and for private portfolios using optimistic comparables. The contrarian point is that this debate is about timing, not terminal value: a business can be exceptional and still be un-investable at the wrong price for years, especially when the key monetization step is still several years out.

For listed equities, there is no clean direct trade from this headline. Any putative read-through to NVDA is too remote to size meaningfully; the data-center-in-space angle is a 2028+ option, not a 1-quarter driver. If anything, the best use of this news is as a discipline signal: demand verified commercial traction and tighter private-mark pricing before adding exposure to frontier-tech stories.

Key Decisions for Investors

• Stay flat on SPCX in the listed-book; if we have private/secondary exposure, use any rally to trim and wait for the next verified tender or financing print. Risk/reward is poor until an operating milestone narrows the valuation gap.
• Set a 1-3 month alert on any SpaceX secondary transaction or fund mark change; a lower clearing price would confirm de-rating risk across private growth portfolios, while an unchanged/upsized print would falsify the bearish thesis.
• Do not initiate a directional NVDA trade on this headline alone. Any benefit from hypothetical space-data-center demand is too far out to justify size; reassess only if customer commitments or capex evidence emerges over the next 12-18 months.
• Use this as a screen to reduce exposure to other long-duration, pre-profitability private tech names if they are being valued on TAM rather than current monetization. The next catalyst is funding-market repricing, not product news.